J. Mel Sorensen

President, Chief Executive Officer and Chair of the Board

CEO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Galera Therapeutics, Inc. (GRTXD)	M.D., President and Chief Executive Officer	$619,479	—	—	$114,342	—	$14,000	$747,821
2024	Galera Therapeutics, Inc. (GRTXD)	M.D., President and Chief Executive Officer	$619,479	—	—	—	—	$13,800	$633,279
2022	Galera Therapeutics, Inc. (GRTXD)	M.D., President and Chief Executive Officer	$596,860	—	—	$453,096	$295,446	$16,045	$1,361,448
2021	Galera Therapeutics, Inc. (GRTXD)	M.D., President and Chief Executive Officer	$568,438	—	—	$1,713,905	$240,733	$11,600	$2,534,676
2020	Galera Therapeutics, Inc. (GRTXD)	M.D., President and Chief Executive Officer	$545,700	—	—	$2,055,977	$345,155	$11,400	$2,958,232
2019	Galera Therapeutics, Inc. (GRTXD)	M.D., President and Chief Executive Officer	$431,602	—	—	$1,893,771	$139,729	—	$2,465,102
2018	Galera Therapeutics, Inc. (GRTXD)	M.D., President and Chief Executive Officer	$386,388	—	—	—	$135,236	—	$521,624

Earnings-call appearances

No earnings-call appearances recorded yet.